药品注册申请号:022032
申请类型:NDA (新药申请)
申请人:DEXCEL PHARMA
申请人全名:DEXCEL PHARMA TECHNOLOGIES LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 OMEPRAZOLE OMEPRAZOLE TABLET, DELAYED RELEASE;ORAL 20MG Yes Yes None 2007/12/04 2007/12/04 Over-the-counter
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/09/30 SUPPL-57(补充) Approval Labeling STANDARD
2021/10/21 SUPPL-52(补充) Approval Manufacturing (CMC) N/A
2021/07/07 SUPPL-46(补充) Approval Labeling STANDARD
2019/04/08 SUPPL-41(补充) Approval Labeling STANDARD
2017/11/13 SUPPL-38(补充) Approval Labeling STANDARD
2017/10/30 SUPPL-37(补充) Approval Labeling STANDARD
2016/12/01 SUPPL-34(补充) Approval Manufacturing (CMC) STANDARD
2016/02/10 SUPPL-32(补充) Approval Labeling STANDARD
2016/02/08 SUPPL-31(补充) Approval Manufacturing (CMC) STANDARD
2016/01/05 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
2015/08/07 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
2015/06/11 SUPPL-29(补充) Approval Labeling STANDARD
2015/06/01 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
2015/03/30 SUPPL-27(补充) Approval Manufacturing (CMC) STANDARD
2015/03/06 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
2013/09/13 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
2013/08/16 SUPPL-21(补充) Approval Labeling STANDARD
2012/10/29 SUPPL-20(补充) Approval Labeling STANDARD
2012/09/10 SUPPL-19(补充) Approval Labeling STANDARD
2012/04/09 SUPPL-16(补充) Approval Labeling STANDARD
2011/06/27 SUPPL-12(补充) Approval Labeling UNKNOWN
2010/07/16 SUPPL-8(补充) Approval Labeling STANDARD
2009/09/21 SUPPL-4(补充) Approval Manufacturing (CMC) N/A
2009/04/02 SUPPL-3(补充) Approval Labeling STANDARD
2007/12/04 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
001 9023391 2025/08/16 Y 2015/06/03 PDF格式
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
本品无治疗等效药品
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database